Αποτελέσματα Αναζήτησης
21 Μαρ 2022 · This narrative review aims to describe the current knowledge on the clinical features of SARS-CoV-2 infection in older adults, focusing on the heterogeneity of clinical presentation and the health-related conditions that might determine a different clinical picture of this disease in advanced age.
19 Μαΐ 2021 · Observational studies including older adults (age ≥ 60 years) with COVID-19 infection and reporting clinical characteristics or outcome were included. Primary outcome was assessing weighted pooled prevalence (WPP) of severity and outcomes.
12 Ιουλ 2024 · Intravenous (IV) infusions at a healthcare facility for 3 consecutive days. Molnupiravir (Lagevrio) Antiviral. Adults. Start as soon as possible; must begin within 5 days of when symptoms start. Taken at home by mouth (orally) Some treatments might have side effects or interact with other medications you are taking.
16 Σεπ 2020 · In the line of therapeutic options for SARS and MERS, this study aims to summarize the current clinical evidence of treatment options for COVID-19. In general, the combination of antibiotics, ribavirin, and corticosteroids was considered as a standard treatment for patients with SARS.
14 Σεπ 2021 · These findings could suggest a connection between the diminished naive TCR repertoire of older individuals before SARS-CoV-2 infection and worsened disease outcome. Lymphopenia
13 Μαΐ 2020 · The disease caused by SARS‐CoV‐2, coronavirus disease 2019 (COVID‐19), presents flu‐like symptoms which can become serious in high‐risk individuals. Here, we provide an overview of the known clinical features and treatment options for COVID‐19.
The clinical characteristics at onset are influenced by the presence of common health-related conditions in older people, such as comorbidity, disability and frailty, and not simply by chronological age.
